Cotrimoxazole therapy ofToxoplasma gondii encephalitis in AIDS patients
- 1 February 1992
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 11 (2) , 125-130
- https://doi.org/10.1007/bf01967063
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- In vitro effects of folate inhibitors on Toxoplasma gondiiAntimicrobial Agents and Chemotherapy, 1989
- Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndromeThe American Journal of Medicine, 1989
- Treatment and Prophylaxis ofIsospora belliInfection in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1989
- Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndromeThe American Journal of Medicine, 1988
- Toxoplasmic EncephalitisThe Journal of Infectious Diseases, 1988
- Assessment of therapy for toxoplasma encephalitisThe American Journal of Medicine, 1987
- Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: Clinical and neuropathological findings in 27 patientsAnnals of Neurology, 1986
- Comparative effects of cotrimoxazole (trimethoprimsulphamethoxazole) and spiramycin in pregnant mice infected with Toxoplasma gondii (Beverley strain)British Journal of Pharmacology, 1985
- OUTBREAK OF CENTRAL-NERVOUS-SYSTEM TOXOPLASMOSIS IN WESTERN EUROPE AND NORTH AMERICAThe Lancet, 1983
- Treating toxoplasmosisJournal of Antimicrobial Chemotherapy, 1979